loading page

Atrial Septal Defect Device Closure in Patients with Metabolic Diseases or Genetic Syndromes
  • +1
  • Keyhan Sayadpour Zanjani,
  • Morteza Heidari,
  • Nima Nazari,
  • Reihaneh Mohsenipour
Keyhan Sayadpour Zanjani
Tehran University of Medical Sciences

Corresponding Author:[email protected]

Author Profile
Morteza Heidari
Tehran University of Medical Sciences
Author Profile
Nima Nazari
Tehran University of Medical Sciences
Author Profile
Reihaneh Mohsenipour
Tehran University of Medical Sciences
Author Profile

Abstract

Concomitant metabolic or genetic syndromes can make atrial septal defect device closure difficult. We searched our database and found eight. The cohort consists of patients with different metabolic and genetic disease . Thromboembolic events and device embolization occurred in some patients. Careful attention is recommended in patients with special diseases.